Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FZC63
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,658
Award facts
- Contract value 100% obligated
- $41,658.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $41,658 by the Defense Logistics Agency on August 29, 2025. The contract, which has an ultimate completion date of September 22, 2025, calls for the delivery of Nexplanon 68 mg implants—a subdermal contraceptive device—to support the medical supply needs of Department of Defense healthcare facilities. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on the open market despite its small business status.
This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, which is valued at $499,999,999 and remains valid through November 2026. Through this overarching contract vehicle, the company provides a comprehensive range of pharmaceutical products to military health facilities nationwide, including prescription medications, biologics, medical consumables, and specialty pharmaceutical items. The company's consistent receipt of delivery orders demonstrates its established role as a critical supplier within the federal pharmaceutical supply chain serving Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB25FZC63?
SPE2DB25FZC63 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 29, 2025.
How much is contract SPE2DB25FZC63 worth?
The government has obligated $41,658 on SPE2DB25FZC63.
Is contract SPE2DB25FZC63 an order under another contract?
Yes. SPE2DB25FZC63 is a delivery order under SPE2DB22D9143, an indefinite delivery contract.
Was contract SPE2DB25FZC63 competed?
The extent of competition for SPE2DB25FZC63 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award